These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Study of alanine aminopeptidase excretion as a test of gentamicin nephrotoxicity. Davey PG; Geddes AM; Cowley DM J Antimicrob Chemother; 1983 May; 11(5):455-65. PubMed ID: 6135686 [TBL] [Abstract][Full Text] [Related]
4. Gentamicin nephrotoxicity in rats is not modified by verapamil. Rodríguez-Barbero A; Bosque E; Gonzalez-Buitrago JM; Garcia-Bastos JL; López-Novoa JM Arch Int Physiol Biochim Biophys; 1993; 101(6):395-7. PubMed ID: 7511434 [TBL] [Abstract][Full Text] [Related]
5. The increase in urinary alanine aminopeptidase excretion associated with enflurane anesthesia is increased further by aminoglycosides. Motuz DJ; Watson WA; Barlow JC; Velasquez NV; Schentag JJ Anesth Analg; 1988 Aug; 67(8):770-4. PubMed ID: 2899408 [TBL] [Abstract][Full Text] [Related]
6. Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin. Rybak MJ; Frankowski JJ; Edwards DJ; Albrecht LM Antimicrob Agents Chemother; 1987 Oct; 31(10):1461-4. PubMed ID: 2893584 [TBL] [Abstract][Full Text] [Related]
7. Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers. Chapelsky MC; Nix DE; Cavanaugh JC; Wilton JH; Norman A; Schentag JJ Drug Saf; 1992; 7(4):304-9. PubMed ID: 1355971 [TBL] [Abstract][Full Text] [Related]
8. Verapamil increases the nephrotoxic potential of gentamicin in rats. Farag MM; Kandil M; Fadali GA Nephron; 1992; 62(1):71-3. PubMed ID: 1436295 [TBL] [Abstract][Full Text] [Related]
9. Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment. Trollfors B; Bergmark J; Hiesche K; Jagenburg R Infection; 1984; 12(1):20-2. PubMed ID: 6142864 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the enzymuria resulting from gentamicin alone and combinations of gentamicin with various beta-lactam antibiotics. Nix DE; Thomas JK; Symonds WT; Spivey JM; Wilton JH; Gagliardi NC; Schentag JJ Ann Pharmacother; 1997 Jun; 31(6):696-703. PubMed ID: 9184707 [TBL] [Abstract][Full Text] [Related]
11. The relationship between enzymuria and kidney enzyme activities in experimental gentamicin nephrotoxicity. Whiting PH; Brown PA Ren Fail; 1996 Nov; 18(6):899-909. PubMed ID: 8948524 [TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of gentamicin and vancomycin given alone and in combination as determined by enzymuria and cortical antibiotic levels in rats. Fauconneau B; Favrelière S; Pariat C; Génévrier A; Courtois P; Piriou A; Bouquet S Ren Fail; 1997 Jan; 19(1):15-22. PubMed ID: 9044448 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin. Gibey R; Dupond JL; Alber D; Leconte des Floris R; Henry JC Clin Chim Acta; 1981 Oct; 116(1):25-34. PubMed ID: 6172216 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine nephrotoxicity and rejection crisis: diagnosis by urinary enzyme excretion. Bornstein B; Arenas J; Morales JM; Praga M; Rodicio JL; Martinez A; Valdivieso L Nephron; 1996; 72(3):402-6. PubMed ID: 8852487 [TBL] [Abstract][Full Text] [Related]
15. Comparison of serum and renal gentamicin concentrations with fractional urinary excretion tests as indicators of nephrotoxicity. Brown SA; Garry FB J Vet Pharmacol Ther; 1988 Dec; 11(4):330-7. PubMed ID: 3210260 [TBL] [Abstract][Full Text] [Related]
16. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model]. Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687 [TBL] [Abstract][Full Text] [Related]
17. Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins. Heinert G; Wyrobnik J; Scherberich J; Mondorf W; Weber W Urol Int; 1982; 37(4):221-35. PubMed ID: 6182668 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low birth weight infants. Giacoia GP; Schentag JJ J Pediatr; 1986 Oct; 109(4):715-9. PubMed ID: 3531452 [TBL] [Abstract][Full Text] [Related]
19. Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity. Olsen KM; Rudis MI; Rebuck JA; Hara J; Gelmont D; Mehdian R; Nelson C; Rupp ME Crit Care Med; 2004 Aug; 32(8):1678-82. PubMed ID: 15286543 [TBL] [Abstract][Full Text] [Related]
20. Investigations on the potential nephrotoxicity of cefazedone and gentamicin and of their combination, in comparison with the combination of cefazolin and cephalothin with gentamicin. Mondorf AW Arzneimittelforschung; 1979; 29(2a):449-52. PubMed ID: 582724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]